::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

MANAGEMENT OF ORAL ANTICOAGULATION THERAPY AFTER GASTROINTESTINAL BLEEDING

AUTHORS:

Dr. Asifa Tehreem, Dr Tabassum Bashir, Dr. Feeha Nizami

ABSTRACT:

Management of patients on antithrombotics undergoing emergency or elective gastrointestinal (GI) endoscopy has become a common and important clinical challenge. The basic aim of the study is to explore and analyze the different management methods of oral anticoagulation therapy after gastrointestinal bleeding. This cross sectional study was conducted in Allied Hospital, Faisalabad during March 2019 to January 2020. This study was done basically by analyzing different management methods of oral anticoagulation therapies which were used after gastrointestinal bleeding. We collect both demographical data and collect the views of patients after GIT bleeding. Then we further analyze this data by using MS excel and find the different values. In critical patients who are actively bleeding with persistent or intermittent haemodynamic instability, coagulation factors should be administered even in the case of therapeutic ranges. If the patient is haemodynamically stable and/or responds sufficiently to resuscitation, it is advisable to simply observe the patient closely and defer endoscopy. We do not recommend bridging anticoagulation therapy in patients with low thromboembolic risk. Another issue is the timing of anticoagulant resumption in patients with clinically significant GI haemorrhage and no source of bleeding identified at endoscopy.